These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Proto-oncogenes and the cardiovascular system. Pollack PS Chest; 1995 Mar; 107(3):826-35. PubMed ID: 7874960 [No Abstract] [Full Text] [Related]
51. [Mechanisms of myocardial hypertrophy]. Komuro I; Yazaki Y Kokyu To Junkan; 1987 Jul; 35(7):695-702. PubMed ID: 2958915 [No Abstract] [Full Text] [Related]
52. MicroRNA-29a is a friend or foe for cardiac hypertrophy? Tao H; Yang JJ; Li J J Am Coll Cardiol; 2014 Aug; 64(8):848. PubMed ID: 25145535 [No Abstract] [Full Text] [Related]
53. [Myocardial hypertrophy caused by hypobaric hypoxia. Studies in male and female rats of various ages]. Buccelli C; Meccariello P; Cacciapuoti A; Errico R; Critelli G; Peschle C Boll Soc Ital Cardiol; 1975; 20(12):1860-6. PubMed ID: 136262 [No Abstract] [Full Text] [Related]
57. [Heart hypertrophy. Determinant factors and molecular mechanisms]. Batlouni M Arq Bras Cardiol; 1995 Dec; 65(6):533-9. PubMed ID: 8731310 [No Abstract] [Full Text] [Related]
58. Pathophysiological considerations in left ventricular hypertrophy. Frohlich ED J Clin Hypertens; 1987 Mar; 3(1):54-65. PubMed ID: 2952767 [TBL] [Abstract][Full Text] [Related]
59. Hemodynamics and other determinants in development of left ventricular hypertrophy. Frohlich ED Fed Proc; 1983 Jul; 42(10):2709-15. PubMed ID: 6222919 [TBL] [Abstract][Full Text] [Related]
60. [Myocardial hypertrophy and fibrosis. New connections with the renin-angiotensin-aldosterone system]. Karlberg BE Lakartidningen; 1993 Jan; 90(1-2):35-6. PubMed ID: 8421400 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]